フィブリンシーラントの市場規模、シェア、成長分析、製品タイプ別、技術別、用途別、エンドユーザー別、地域別 - 産業別予測、2025～2032年

フィブリンシーラントの世界市場規模は、2023年に5億9,290万米ドルと評価され、2024年の6億3,915万米ドルから2032年には11億6,560万米ドルに成長し、予測期間（2025～2032年）のCAGRは7.8％で成長する見通しです。

世界のフィブリンシーラント市場は力強い成長を遂げており、その主な要因は、心臓血管の問題やがんなど、外科的治療を必要とする慢性疾患にかかりやすくなった高齢化社会の影響を受けた外科手術の増加です。手術の頻度や複雑さが増すにつれ、効果的な止血剤への需要が高まり、安定した血栓を素早く形成し、出血量を減らし、回復を早めるフィブリンシーラントが支持されています。さらに、生物学的技術や組換えDNA技術の進歩により、保存期間が延長され、免疫原性リスクが低減された、より安全で効果的なシーラントが製造されつつあり、合成で病原体を含まない選択肢の製造が可能となっています。このような技術革新により、接着性、重合速度、全体的な手術成績が向上し、現代医療におけるフィブリンシーラントの臨床応用が広がっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

フィブリンシーラント市場規模：製品タイプ別およびCAGR（2025～2032年）

• 市場概要
• 液体
  • 冷凍フィブリンシーラント
  • フリーズドライフィブリンシーラント
• パッチ
• 粉
• その他

フィブリンシーラント市場規模：技術別およびCAGR（2025～2032年）

• 市場概要
• ウイルス不活化
• 自己血提供
• 組み換え生産
• その他

フィブリンシーラント市場規模：用途別およびCAGR（2025～2032年）

• 市場概要
• 整形外科
• 心臓血管外科
• 一般外科
• 移植手術
• その他

フィブリンシーラント市場規模：エンドユーザー別およびCAGR（2025～2032年）

• 市場概要
• 病院
• 専門クリニック
• その他

フィブリンシーラント市場規模およびCAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Baxter International（USA）
• CSL Limited（Australia）
• Vivostat A/S（Denmark）
• Grifols, S.A.（Spain）
• Pfizer Inc.（USA）
• Stryker Corporation（USA）
• Hemarus（Australia）
• Asahi Kasei Corporation（Japan）
• Z-Medica（USA）
• Marquee Biosurgical（USA）
• Hualan Biological Engineering（China）
• CryoLife, Inc.（USA）
• Integra LifeSciences Corporation（USA）
• Becton, Dickinson and Company（USA）
• B. Braun SE（Germany）
• Corza Medical（USA/Switzerland）
• Cohera Medical（USA）
• Advanced Medical Solutions Group plc（UK）
• Ocular Therapeutix, Inc.（USA）
• MicroVal（France）

結論と提言

Global Fibrin Sealants Market size was valued at USD 592.9 million in 2023 and is poised to grow from USD 639.15 million in 2024 to USD 1165.6 million by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The global fibrin sealants market is experiencing robust growth, primarily driven by an increase in surgical procedures influenced by an aging population more prone to chronic diseases needing surgical care like cardiovascular issues and cancer. As surgeries become more frequent and complex, the demand for effective hemostatic agents rises, with fibrin sealants being favored for their ability to quickly form stable clots, reduce blood loss, and expedite recovery. Furthermore, advancements in biologic and recombinant DNA technologies are producing safer, more effective sealants with extended shelf lives and reduced immunogenic risks, enabling the production of synthetic and pathogen-free options. These innovations are enhancing adhesion, polymerization speed, and overall surgical outcomes, thereby broadening the clinical adoption of fibrin sealants in modern medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fibrin Sealants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fibrin Sealants Market Segments Analysis

Global Fibrin Sealants Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Liquid, Patches, Powder and Others. Based on Technology, the market is segmented into Viral Inactivation, Autologous Donation, Recombinant Production and Others. Based on Application, the market is segmented into Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fibrin Sealants Market

The global fibrin sealants market is significantly influenced by the increasing volume of surgical procedures taking place across the globe. This rise is largely attributed to the higher prevalence of chronic conditions such as cardiovascular diseases, cancer, and orthopedic issues. Consequently, there is a heightened demand for effective hemostatic agents, particularly fibrin sealants, which facilitate improved surgical outcomes. As more patients undergo surgeries to address these health concerns, the need for reliable and efficient solutions like fibrin sealants continues to expand, further propelling the growth of the market over time.

Restraints in the Global Fibrin Sealants Market

The global fibrin sealants market faces significant restraints due to regulatory challenges and prolonged approval timelines for fibrin sealant products. These obstacles slow down market expansion as the necessity for comprehensive clinical trials and adherence to regulations in various regions extends development periods. Consequently, this limits the introduction of new and innovative fibrin sealant solutions, potentially hindering access to advanced treatment options for healthcare providers and patients alike. As the market grapples with these regulatory complexities, the overall growth and evolution of fibrin sealant offerings may be significantly affected, impacting industry dynamics in the long run.

Market Trends of the Global Fibrin Sealants Market

The Global Fibrin Sealants market is witnessing a significant surge, predominantly fueled by the rising preference for minimally invasive surgeries. As healthcare providers increasingly prioritize patient safety and quicker recovery times, fibrin sealants have emerged as a vital tool, enhancing surgical efficacy by reducing blood loss and promoting faster healing. This trend is particularly evident in critical fields such as cardiovascular and orthopedic surgery, where precision and rapid postoperative recovery are paramount. As a result, the demand for these biological adhesives is projected to escalate, positioning fibrin sealants as indispensable components in modern surgical practice, thereby shaping the future of surgical interventions worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Fibrin Sealants Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Liquid
  • Frozen fibrin sealants
  • Freeze dried fibrin sealants
• Patches
• Powder
• Others

Global Fibrin Sealants Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Viral Inactivation
• Autologous Donation
• Recombinant Production
• Others

Global Fibrin Sealants Market Size by Application & CAGR (2025-2032)

• Market Overview
• Orthopedic Surgery
• Cardiovascular surgery
• General Surgery
• Transplant Surgery
• Others

Global Fibrin Sealants Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Fibrin Sealants Market Size & CAGR (2025-2032)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Baxter International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivostat A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemarus (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Z-Medica (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marquee Biosurgical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Medical (USA/Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Therapeutix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVal (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations